FDA OKs rare neurologic disease treatment
Monday, September 15, 2008 - 09:49
in Health & Medicine
WASHINGTON, Sept. 15 (UPI) -- The U.S. Food and Drug Administration approved an immune globulin product called Gamunex for treatment of chronic inflammatory demyelinating polyneuropathy.